Diabetes is a major risk factor for mortality after lung transplantation

American Journal of Transplantation

Volumn 14, Issue 2, 2014, Pages 438-445

  Hackman, K L ^a,b   Bailey, M J ^a   Snell, G I ^a,b   Bach, L A ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b ALFRED HOSPITAL   (Australia)

Author keywords

Bronchiolitis obliterans syndrome; diabetes mellitus; lung transplantation; mortality; time dependent analysis

Indexed keywords

ADULT; COMPLICATION; FEMALE; FOLLOW UP; GRAFT REJECTION; HUMAN; LUNG DISEASES; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RISK FACTOR; SURVIVAL RATE;

ADULT; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; LUNG DISEASES; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RISK FACTORS; SURVIVAL RATE;

EID: 84895058683     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12561     Document Type: Article

References (38)

1. Australia and New Zealand Cardiothoracic Organ Transplant Registry Sixteenth Annual Report 2012. Available at: http://www.anzcotr.org.au/ uploadedFiles/1279001464281-56522.pdf. Accessed April 8, 2013.
2. Stehlik J, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart, Lung Transplantation: 29th official adult heart transplant report-2012. J Heart Lung Transplant 2012; 31: 1052-1064.
3. Clayton P, Campbel S, Hurst K, McDonald S, Chadban S., ANZDATA Registry Thirty Fourth Annual Report 2010 Adelaide: Australia and New Zealand Dialysis and Transplant registry; 2011. Available at: http://www.anzdata.org.au/anzdata/ AnzdataReport/34thReport/2011c08-transplantation-v1.7.pdf. Accessed April 2, 2013.
4. ANZLT Registry Report 2010. Available at: http://www.anzltr.org/thisYear/ report.pdf. Accessed October 16, 2011.
5. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ., Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178-185.
6. Watt KD, Pedersen RA, Kremers WK, Heimbach JK, Charlton MR., Evolution of causes and risk factors for mortality post-liver transplant: Results of the NIDDK long-term follow-up study. Am J Transplant 2010; 10: 1420-1427.
7. Christie JD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart, Lung Transplantation: 29th adult lung, heart-lung transplant report-2012. J Heart Lung Transplant 2012; 31: 1073-1086.
8. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931-940.
9. Davidson J, Wilkinson A, Dantal J, et al. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation 2003; 75 (10 Suppl): SS3-SS24.
10. Wilkinson A, Davidson J, Dotta F, et al. Guidelines for the treatment, management of new-onset diabetes after transplantation. Clin Transplant 2005; 19: 291-298.
11. Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC., Posttransplantation diabetes: A systematic review of the literature. Diabetes Care 2002; 25: 583-592.
12. Moon JI, Barbeito R, Faradji RN, Gaynor JJ, Tzakis AG., Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: Long-term follow up. Transplantation 2006; 82: 1625-1628.
13. Bradbury RA, Shirkhedkar D, Glanville AR, Campbell LV., Prior diabetes mellitus is associated with increased morbidity in cystic fibrosis patients undergoing bilateral lung transplantation: An 'orphan' area? A retrospective case-control study. Int Med J 2009; 39: 384-388.
14. Ollech JE, Kramer MR, Peled N, et al. Post-transplant diabetes mellitus in lung transplant recipients: Incidence, risk factors. Eur J Cardiothorac Surg 2008; 33: 844-848.
15. Lyu DM, Zamora MR., Medical complications of lung transplantation. Proc Am Thorac Soc 2009; 6: 101-107.
16. Corris PA., Lung transplantation for cystic fibrosis and bronchiectasis. Semin Respir Crit Care Med 2013; 34: 297-304.
17. World Health Organisation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: Report of a WHO/IDF consultation. 2006. Available at: http://whqlibdoc.who.int/publications/2006/9241594934-eng.pdf. Accessed August 19, 2011.
18. Snell GI, Esmore DS, Westall GP, et al. The Alfred Hospital lung transplant experience. Clin Transpl 2007; 131-144.
19. Gabbay E, Williams TJ, Griffiths AP, et al. Maximizing the utilization of donor organs offered for lung transplantation. Am J Respir Crit Care Med 1999; 160: 265-271.
20. Snell GI, Griffiths A, Macfarlane L, et al. Maximizing thoracic organ transplant opportunities: The importance of efficient coordination. J Heart Lung Transplantat 2000; 19: 401-407.
21. Orens JB, Estenne M, Arcasoy S, et al. International guidelines for the selection of lung transplant candidates: 2006 update-A consensus report from the Pulmonary Scientific Council of the International Society for Heart, Lung Transplantation. J Heart Lung Transplant 2006; 25: 745-755.
22. Esmore DS, Brown R, Buckland M, et al. Techniques, results in bilateral sequential single lung transplantation. The National Heart, Lung Replacement Service. J Card Surg 1994; 9: 1-14.
23. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria. J Heart Lung Transplant 2002; 21: 297-310.
24. Hackman KL, Snell GI, Bach LA., An unexpectedly high prevalence of undiagnosed diabetes in patients awaiting lung transplantation. J Heart Lung Transplant 2013; 32: 86-91.
25. Plantier L, Skhiri N, Biondi G, et al. Impact of previous cardiovascular disease on the outcome of lung transplantation. J Heart Lung Transplant 2010; 29: 1270-1276.
26. McKeever TM, Weston PJ, Hubbard R, Fogarty A., Lung function and glucose metabolism: An analysis of data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2005; 161: 546-556.
27. Klein OL, Krishnan JA, Glick S, Smith LJ., Systematic review of the association between lung function and Type 2 diabetes mellitus. Diabet Med 2010; 27: 977-987.
28. Yeh HC, Punjabi NM, Wang NY, et al. Cross-sectional, prospective study of lung function in adults with type 2 diabetes: The Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care 2008; 31: 741-746.
29. Hayes D Jr., A review of bronchiolitis obliterans syndrome and therapeutic strategies. J Cardiothorac Surg 2011; 6: 92.
30. Boehler A, Estenne M., Post-transplant bronchiolitis obliterans. Eur Respir J 2003; 22: 1007-1018.
31. Stramer BM, Mori R, Martin P., The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair. J Investig Dermatol 2007; 127: 1009-1017.
32. Popov D, Simionescu M., Alterations of lung structure in experimental diabetes, and diabetes associated with hyperlipidaemia in hamsters. Eur Respir J 1997; 10: 1850-1858.
33. Rask-Madsen C, King GL., Vascular complications of diabetes: Mechanisms of injury and protective factors. Cell Metab 2013; 17: 20-33.
34. Goh SY, Cooper ME., Clinical review: The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 2008; 93: 1143-1152.
35. Selvin E, Halushka M, Rawlings A, et al. sRAGE, risk of diabetes, cardiovascular disease, death. Diabetes 2013; 62: 2116-2121.
36. Yang SJ, Kim S, Hwang SY, et al. Association between sRAGE, esRAGE levels, vascular inflammation: Analysis with (18)F-fluorodeoxyglucose positron emission tomography. Atherosclerosis 2012; 220: 402-406.
37. Colhoun HM, Betteridge DJ, Durrington P, et al. Total soluble, endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: An analysis from the CARDS trial. Diabetes 2011; 60: 2379-2385.
38. Shah RJ, Bellamy SL, Lee JC, et al. Early plasma soluble receptor for advanced glycation end-product levels are associated with bronchiolitis obliterans syndrome. Am J Transplant 2013; 13: 754-759.